img

Global Bioequivalent Peptide Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bioequivalent Peptide Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A bioequivalent peptide drug is one that has similar structure and function, and exhibits similar pharmacokinetic and pharmacodynamic properties in vivo to the original brand drug or an approved reference product. These drugs are usually synthesized through genetic recombination technology and undergo rigorous research and development and approval procedures.
Bioequivalent Peptide Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bioequivalent Peptide Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Short Bowel Syndrome and Osteoporosis are the major drivers for the industry.
The development and production of bioequivalent peptide drugs usually requires detailed comparison and analysis, including in vitro and in vivo experimental evaluation, and comparison of clinical trial data. Bioequivalent peptide drugs have a wide range of applications in drug replacement, therapeutic expansion, and biosimilars.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bioequivalent Peptide Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Eli Lilly and Company
Alvogen
Pfenex
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Ambio Pharmaceuticals
Jiangsu Sinopep Allsino Biopharmaceutical
Shanghai Shyndec Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Shanghai United Cell Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide Biotechnology
Segment by Type
Teriparatide(Forteo)
Teduglutide(Gattex)
Liraglutide(Victoza)

Segment by Application


Short Bowel Syndrome
Osteoporosis
Type 2 Diabetes
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bioequivalent Peptide Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bioequivalent Peptide Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bioequivalent Peptide Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bioequivalent Peptide Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bioequivalent Peptide Drugs introduction, etc. Bioequivalent Peptide Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bioequivalent Peptide Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Bioequivalent Peptide Drugs Market Overview
1.1 Bioequivalent Peptide Drugs Product Overview
1.2 Bioequivalent Peptide Drugs Market Segment by Type
1.2.1 Teriparatide(Forteo)
1.2.2 Teduglutide(Gattex)
1.2.3 Liraglutide(Victoza)
1.3 Global Bioequivalent Peptide Drugs Market Size by Type
1.3.1 Global Bioequivalent Peptide Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Bioequivalent Peptide Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Bioequivalent Peptide Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bioequivalent Peptide Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Bioequivalent Peptide Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Bioequivalent Peptide Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Bioequivalent Peptide Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Bioequivalent Peptide Drugs Sales Breakdown by Type (2018-2024)
2 Global Bioequivalent Peptide Drugs Market Competition by Company
2.1 Global Top Players by Bioequivalent Peptide Drugs Sales (2018-2024)
2.2 Global Top Players by Bioequivalent Peptide Drugs Revenue (2018-2024)
2.3 Global Top Players by Bioequivalent Peptide Drugs Price (2018-2024)
2.4 Global Top Manufacturers Bioequivalent Peptide Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bioequivalent Peptide Drugs Market Competitive Situation and Trends
2.5.1 Bioequivalent Peptide Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Bioequivalent Peptide Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bioequivalent Peptide Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Bioequivalent Peptide Drugs Market
2.8 Key Manufacturers Bioequivalent Peptide Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bioequivalent Peptide Drugs Status and Outlook by Region
3.1 Global Bioequivalent Peptide Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bioequivalent Peptide Drugs Historic Market Size by Region
3.2.1 Global Bioequivalent Peptide Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Bioequivalent Peptide Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Bioequivalent Peptide Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Bioequivalent Peptide Drugs Forecasted Market Size by Region
3.3.1 Global Bioequivalent Peptide Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Bioequivalent Peptide Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Bioequivalent Peptide Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bioequivalent Peptide Drugs by Application
4.1 Bioequivalent Peptide Drugs Market Segment by Application
4.1.1 Short Bowel Syndrome
4.1.2 Osteoporosis
4.1.3 Type 2 Diabetes
4.1.4 Others
4.2 Global Bioequivalent Peptide Drugs Market Size by Application
4.2.1 Global Bioequivalent Peptide Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Bioequivalent Peptide Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Bioequivalent Peptide Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bioequivalent Peptide Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Bioequivalent Peptide Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Bioequivalent Peptide Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Bioequivalent Peptide Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Bioequivalent Peptide Drugs Sales Breakdown by Application (2018-2024)
5 North America Bioequivalent Peptide Drugs by Country
5.1 North America Bioequivalent Peptide Drugs Historic Market Size by Country
5.1.1 North America Bioequivalent Peptide Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bioequivalent Peptide Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Bioequivalent Peptide Drugs Sales in Value by Country (2018-2024)
5.2 North America Bioequivalent Peptide Drugs Forecasted Market Size by Country
5.2.1 North America Bioequivalent Peptide Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Bioequivalent Peptide Drugs Sales in Value by Country (2024-2029)
6 Europe Bioequivalent Peptide Drugs by Country
6.1 Europe Bioequivalent Peptide Drugs Historic Market Size by Country
6.1.1 Europe Bioequivalent Peptide Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bioequivalent Peptide Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Bioequivalent Peptide Drugs Sales in Value by Country (2018-2024)
6.2 Europe Bioequivalent Peptide Drugs Forecasted Market Size by Country
6.2.1 Europe Bioequivalent Peptide Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Bioequivalent Peptide Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Bioequivalent Peptide Drugs by Region
7.1 Asia-Pacific Bioequivalent Peptide Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Bioequivalent Peptide Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bioequivalent Peptide Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Bioequivalent Peptide Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Bioequivalent Peptide Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Bioequivalent Peptide Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bioequivalent Peptide Drugs Sales in Value by Region (2024-2029)
8 Latin America Bioequivalent Peptide Drugs by Country
8.1 Latin America Bioequivalent Peptide Drugs Historic Market Size by Country
8.1.1 Latin America Bioequivalent Peptide Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bioequivalent Peptide Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Bioequivalent Peptide Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Bioequivalent Peptide Drugs Forecasted Market Size by Country
8.2.1 Latin America Bioequivalent Peptide Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bioequivalent Peptide Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Bioequivalent Peptide Drugs by Country
9.1 Middle East and Africa Bioequivalent Peptide Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Bioequivalent Peptide Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bioequivalent Peptide Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Bioequivalent Peptide Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Bioequivalent Peptide Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Bioequivalent Peptide Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bioequivalent Peptide Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eli Lilly and Company
10.1.1 Eli Lilly and Company Company Information
10.1.2 Eli Lilly and Company Introduction and Business Overview
10.1.3 Eli Lilly and Company Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Eli Lilly and Company Bioequivalent Peptide Drugs Products Offered
10.1.5 Eli Lilly and Company Recent Development
10.2 Alvogen
10.2.1 Alvogen Company Information
10.2.2 Alvogen Introduction and Business Overview
10.2.3 Alvogen Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Alvogen Bioequivalent Peptide Drugs Products Offered
10.2.5 Alvogen Recent Development
10.3 Pfenex
10.3.1 Pfenex Company Information
10.3.2 Pfenex Introduction and Business Overview
10.3.3 Pfenex Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfenex Bioequivalent Peptide Drugs Products Offered
10.3.5 Pfenex Recent Development
10.4 HEC Pharm
10.4.1 HEC Pharm Company Information
10.4.2 HEC Pharm Introduction and Business Overview
10.4.3 HEC Pharm Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 HEC Pharm Bioequivalent Peptide Drugs Products Offered
10.4.5 HEC Pharm Recent Development
10.5 Bachem
10.5.1 Bachem Company Information
10.5.2 Bachem Introduction and Business Overview
10.5.3 Bachem Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bachem Bioequivalent Peptide Drugs Products Offered
10.5.5 Bachem Recent Development
10.6 Bharat Pharmaceuticals
10.6.1 Bharat Pharmaceuticals Company Information
10.6.2 Bharat Pharmaceuticals Introduction and Business Overview
10.6.3 Bharat Pharmaceuticals Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bharat Pharmaceuticals Bioequivalent Peptide Drugs Products Offered
10.6.5 Bharat Pharmaceuticals Recent Development
10.7 Kingpep Biotechnology
10.7.1 Kingpep Biotechnology Company Information
10.7.2 Kingpep Biotechnology Introduction and Business Overview
10.7.3 Kingpep Biotechnology Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Kingpep Biotechnology Bioequivalent Peptide Drugs Products Offered
10.7.5 Kingpep Biotechnology Recent Development
10.8 Ambio Pharmaceuticals
10.8.1 Ambio Pharmaceuticals Company Information
10.8.2 Ambio Pharmaceuticals Introduction and Business Overview
10.8.3 Ambio Pharmaceuticals Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Ambio Pharmaceuticals Bioequivalent Peptide Drugs Products Offered
10.8.5 Ambio Pharmaceuticals Recent Development
10.9 Jiangsu Sinopep Allsino Biopharmaceutical
10.9.1 Jiangsu Sinopep Allsino Biopharmaceutical Company Information
10.9.2 Jiangsu Sinopep Allsino Biopharmaceutical Introduction and Business Overview
10.9.3 Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Products Offered
10.9.5 Jiangsu Sinopep Allsino Biopharmaceutical Recent Development
10.10 Shanghai Shyndec Pharmaceutical
10.10.1 Shanghai Shyndec Pharmaceutical Company Information
10.10.2 Shanghai Shyndec Pharmaceutical Introduction and Business Overview
10.10.3 Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Products Offered
10.10.5 Shanghai Shyndec Pharmaceutical Recent Development
10.11 Shenzhen Salubris Pharmaceuticals
10.11.1 Shenzhen Salubris Pharmaceuticals Company Information
10.11.2 Shenzhen Salubris Pharmaceuticals Introduction and Business Overview
10.11.3 Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Products Offered
10.11.5 Shenzhen Salubris Pharmaceuticals Recent Development
10.12 Shanghai United Cell Biotechnology
10.12.1 Shanghai United Cell Biotechnology Company Information
10.12.2 Shanghai United Cell Biotechnology Introduction and Business Overview
10.12.3 Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Products Offered
10.12.5 Shanghai United Cell Biotechnology Recent Development
10.13 Shenzhen JYMed Technology
10.13.1 Shenzhen JYMed Technology Company Information
10.13.2 Shenzhen JYMed Technology Introduction and Business Overview
10.13.3 Shenzhen JYMed Technology Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Shenzhen JYMed Technology Bioequivalent Peptide Drugs Products Offered
10.13.5 Shenzhen JYMed Technology Recent Development
10.14 Wuxi Asiapeptide Biotechnology
10.14.1 Wuxi Asiapeptide Biotechnology Company Information
10.14.2 Wuxi Asiapeptide Biotechnology Introduction and Business Overview
10.14.3 Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Products Offered
10.14.5 Wuxi Asiapeptide Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bioequivalent Peptide Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bioequivalent Peptide Drugs Industrial Chain Analysis
11.4 Bioequivalent Peptide Drugs Market Dynamics
11.4.1 Bioequivalent Peptide Drugs Industry Trends
11.4.2 Bioequivalent Peptide Drugs Market Drivers
11.4.3 Bioequivalent Peptide Drugs Market Challenges
11.4.4 Bioequivalent Peptide Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bioequivalent Peptide Drugs Distributors
12.3 Bioequivalent Peptide Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Teriparatide(Forteo)
Table 2. Major Company of Teduglutide(Gattex)
Table 3. Major Company of Liraglutide(Victoza)
Table 4. Global Bioequivalent Peptide Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (Units)
Table 6. Global Bioequivalent Peptide Drugs Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (US& Million)
Table 8. Global Bioequivalent Peptide Drugs Market Share in Value by Type (2018-2024)
Table 9. Global Bioequivalent Peptide Drugs Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Bioequivalent Peptide Drugs Sales by Type (2024-2029) & (Units)
Table 11. Global Bioequivalent Peptide Drugs Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Bioequivalent Peptide Drugs Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Bioequivalent Peptide Drugs Sales Market Share in Value by Type (2024-2029)
Table 14. Global Bioequivalent Peptide Drugs Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (Units)
Table 16. North America Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Bioequivalent Peptide Drugs Sales (Units) by Type (2018-2024)
Table 18. Europe Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Bioequivalent Peptide Drugs Sales (Units) by Type (2018-2024)
Table 20. Asia-Pacific Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Bioequivalent Peptide Drugs Sales (Units) by Type (2018-2024)
Table 22. Latin America Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Bioequivalent Peptide Drugs Sales (Units) by Type (2018-2024)
Table 24. Middle East and Africa Bioequivalent Peptide Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Bioequivalent Peptide Drugs Sales by Company (2018-2024) & (Units)
Table 26. Global Bioequivalent Peptide Drugs Sales Share by Company (2018-2024)
Table 27. Global Bioequivalent Peptide Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Bioequivalent Peptide Drugs Revenue Share by Company (2018-2024)
Table 29. Global Market Bioequivalent Peptide Drugs Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Bioequivalent Peptide Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Bioequivalent Peptide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bioequivalent Peptide Drugs as of 2022)
Table 33. Date of Key Manufacturers Enter into Bioequivalent Peptide Drugs Market
Table 34. Key Manufacturers Bioequivalent Peptide Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Bioequivalent Peptide Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Bioequivalent Peptide Drugs Sales by Region (2018-2024) & (Units)
Table 38. Global Bioequivalent Peptide Drugs Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Bioequivalent Peptide Drugs Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Bioequivalent Peptide Drugs Sales Market Share in Value by Region (2018-2024)
Table 41. Global Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Bioequivalent Peptide Drugs Sales by Region (2024-2029) & (Units)
Table 43. Global Bioequivalent Peptide Drugs Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Bioequivalent Peptide Drugs Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Bioequivalent Peptide Drugs Sales Market Share in Value by Region (2024-2029)
Table 46. Global Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Bioequivalent Peptide Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Bioequivalent Peptide Drugs Sales by Application (2018-2024) & (Units)
Table 49. Global Bioequivalent Peptide Drugs Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Bioequivalent Peptide Drugs Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Bioequivalent Peptide Drugs Sales Market Share in Value by Application (2018-2024)
Table 52. Global Bioequivalent Peptide Drugs Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Bioequivalent Peptide Drugs Sales by Application (2024-2029) & (Units)
Table 54. Global Bioequivalent Peptide Drugs Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Bioequivalent Peptide Drugs Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Bioequivalent Peptide Drugs Sales Market Share in Value by Application (2024-2029)
Table 57. Global Bioequivalent Peptide Drugs Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Bioequivalent Peptide Drugs Sales by Application (2018-2024) (Units)
Table 59. North America Bioequivalent Peptide Drugs Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Bioequivalent Peptide Drugs Sales by Application (2018-2024) (Units)
Table 61. Europe Bioequivalent Peptide Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Bioequivalent Peptide Drugs Sales by Application (2018-2024) (Units)
Table 63. Asia-Pacific Bioequivalent Peptide Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Bioequivalent Peptide Drugs Sales by Application (2018-2024) (Units)
Table 65. Latin America Bioequivalent Peptide Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Bioequivalent Peptide Drugs Sales by Application (2018-2024) (Units)
Table 67. Middle East and Africa Bioequivalent Peptide Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (Units)
Table 69. North America Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2018-2024)
Table 72. North America Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (Units)
Table 73. North America Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (Units)
Table 77. Europe Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (Units)
Table 81. Europe Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Bioequivalent Peptide Drugs Sales by Region (2018-2024) & (Units)
Table 85. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Bioequivalent Peptide Drugs Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Bioequivalent Peptide Drugs Sales by Region (2024-2029) & (Units)
Table 89. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Bioequivalent Peptide Drugs Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (Units)
Table 93. Latin America Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (Units)
Table 97. Latin America Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (Units)
Table 101. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Bioequivalent Peptide Drugs Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (Units)
Table 105. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Bioequivalent Peptide Drugs Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share in Value by Country (2024-2029)
Table 108. Eli Lilly and Company Company Information
Table 109. Eli Lilly and Company Introduction and Business Overview
Table 110. Eli Lilly and Company Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Eli Lilly and Company Bioequivalent Peptide Drugs Product
Table 112. Eli Lilly and Company Recent Development
Table 113. Alvogen Company Information
Table 114. Alvogen Introduction and Business Overview
Table 115. Alvogen Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Alvogen Bioequivalent Peptide Drugs Product
Table 117. Alvogen Recent Development
Table 118. Pfenex Company Information
Table 119. Pfenex Introduction and Business Overview
Table 120. Pfenex Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Pfenex Bioequivalent Peptide Drugs Product
Table 122. Pfenex Recent Development
Table 123. HEC Pharm Company Information
Table 124. HEC Pharm Introduction and Business Overview
Table 125. HEC Pharm Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. HEC Pharm Bioequivalent Peptide Drugs Product
Table 127. HEC Pharm Recent Development
Table 128. Bachem Company Information
Table 129. Bachem Introduction and Business Overview
Table 130. Bachem Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Bachem Bioequivalent Peptide Drugs Product
Table 132. Bachem Recent Development
Table 133. Bharat Pharmaceuticals Company Information
Table 134. Bharat Pharmaceuticals Introduction and Business Overview
Table 135. Bharat Pharmaceuticals Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Bharat Pharmaceuticals Bioequivalent Peptide Drugs Product
Table 137. Bharat Pharmaceuticals Recent Development
Table 138. Kingpep Biotechnology Company Information
Table 139. Kingpep Biotechnology Introduction and Business Overview
Table 140. Kingpep Biotechnology Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Kingpep Biotechnology Bioequivalent Peptide Drugs Product
Table 142. Kingpep Biotechnology Recent Development
Table 143. Ambio Pharmaceuticals Company Information
Table 144. Ambio Pharmaceuticals Introduction and Business Overview
Table 145. Ambio Pharmaceuticals Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Ambio Pharmaceuticals Bioequivalent Peptide Drugs Product
Table 147. Ambio Pharmaceuticals Recent Development
Table 148. Jiangsu Sinopep Allsino Biopharmaceutical Company Information
Table 149. Jiangsu Sinopep Allsino Biopharmaceutical Introduction and Business Overview
Table 150. Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Product
Table 152. Jiangsu Sinopep Allsino Biopharmaceutical Recent Development
Table 153. Shanghai Shyndec Pharmaceutical Company Information
Table 154. Shanghai Shyndec Pharmaceutical Introduction and Business Overview
Table 155. Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Product
Table 157. Shanghai Shyndec Pharmaceutical Recent Development
Table 158. Shenzhen Salubris Pharmaceuticals Company Information
Table 159. Shenzhen Salubris Pharmaceuticals Introduction and Business Overview
Table 160. Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Product
Table 162. Shenzhen Salubris Pharmaceuticals Recent Development
Table 163. Shanghai United Cell Biotechnology Company Information
Table 164. Shanghai United Cell Biotechnology Introduction and Business Overview
Table 165. Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Product
Table 167. Shanghai United Cell Biotechnology Recent Development
Table 168. Shenzhen JYMed Technology Company Information
Table 169. Shenzhen JYMed Technology Introduction and Business Overview
Table 170. Shenzhen JYMed Technology Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Shenzhen JYMed Technology Bioequivalent Peptide Drugs Product
Table 172. Shenzhen JYMed Technology Recent Development
Table 173. Wuxi Asiapeptide Biotechnology Company Information
Table 174. Wuxi Asiapeptide Biotechnology Introduction and Business Overview
Table 175. Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Product
Table 177. Wuxi Asiapeptide Biotechnology Recent Development
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Bioequivalent Peptide Drugs Market Trends
Table 181. Bioequivalent Peptide Drugs Market Drivers
Table 182. Bioequivalent Peptide Drugs Market Challenges
Table 183. Bioequivalent Peptide Drugs Market Restraints
Table 184. Bioequivalent Peptide Drugs Distributors List
Table 185. Bioequivalent Peptide Drugs Downstream Customers
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Bioequivalent Peptide Drugs Product Picture
Figure 2. Global Bioequivalent Peptide Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bioequivalent Peptide Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Bioequivalent Peptide Drugs Sales Status and Outlook (2018-2029) & (Units)
Figure 5. Product Picture of Teriparatide(Forteo)
Figure 6. Global Teriparatide(Forteo) Sales YoY Growth (2018-2029) & (Units)
Figure 7. Product Picture of Teduglutide(Gattex)
Figure 8. Global Teduglutide(Gattex) Sales YoY Growth (2018-2029) & (Units)
Figure 9. Product Picture of Liraglutide(Victoza)
Figure 10. Global Liraglutide(Victoza) Sales YoY Growth (2018-2029) & (Units)
Figure 11. Global Bioequivalent Peptide Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Bioequivalent Peptide Drugs Sales Market Share by Type in 2022 & 2029
Figure 13. North America Bioequivalent Peptide Drugs Sales Market Share in Volume by Type in 2022
Figure 14. North America Bioequivalent Peptide Drugs Sales Market Share in Value by Type in 2022
Figure 15. Europe Bioequivalent Peptide Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Europe Bioequivalent Peptide Drugs Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Value by Type in 2022
Figure 19. Latin America Bioequivalent Peptide Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Bioequivalent Peptide Drugs Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Bioequivalent Peptide Drugs Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Bioequivalent Peptide Drugs Revenue in 2022
Figure 25. Bioequivalent Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Short Bowel Syndrome
Figure 27. Global Short Bowel Syndrome Sales YoY Growth (2018-2029) & (Units)
Figure 28. Product Picture of Osteoporosis
Figure 29. Global Osteoporosis Sales YoY Growth (2018-2029) & (Units)
Figure 30. Product Picture of Type 2 Diabetes
Figure 31. Global Type 2 Diabetes Sales YoY Growth (2018-2029) & (Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (Units)
Figure 34. Global Bioequivalent Peptide Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Bioequivalent Peptide Drugs Sales Market Share by Application in 2022 & 2029
Figure 36. North America Bioequivalent Peptide Drugs Sales Market Share in Volume by Application in 2022
Figure 37. North America Bioequivalent Peptide Drugs Sales Market Share in Value by Application in 2022
Figure 38. Europe Bioequivalent Peptide Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Europe Bioequivalent Peptide Drugs Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Bioequivalent Peptide Drugs Sales Market Share in Value by Application in 2022
Figure 42. Latin America Bioequivalent Peptide Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Bioequivalent Peptide Drugs Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Bioequivalent Peptide Drugs Manufacturing Cost Structure
Figure 47. Bioequivalent Peptide Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries